Department of Medicine

March 17, 2022

Blood test figures in cancer risk for people with HIV

A Vanderbilt study found that, among adult patients with HIV, those who have lower counts of certain types of blood cells have a markedly higher risk of developing cancer.

P. Brent Ferrell, MD, is part of a multidisciplinary team studying new approaches to understand and treat cancer.
March 17, 2022

Ferrell lands Mark Foundation for Cancer Research award

Vanderbilt’s Brent Ferrell, MD, is one of the recipients a 2022 Endeavor Award from the The Mark Foundation for Cancer Research.

March 17, 2022

Study compares kidney injury risk for COVID, flu patients

A Vanderbilt study found that renin-angiotensin-aldosterone system (RAASi) inhibitor drugs, which are commonly used to regulate high blood pressure, do not disproportionately increase the risk of acute kidney injury (AKI) in patients with COVID-19 compared to patients hospitalized with influenza.

March 17, 2022

Talbot named to infection prevention society’s leadership

Vanderbilt’s Tom Talbot, MD, MPH, was recently elected to serve in the leadership of the Society for Healthcare Epidemiology of America.

José Ontiveros, center, and his wife, Isela Morales, to his left, are surrounded by some of the team members who helped save his life as he battled post-COVID complications, including from left, infectious disease specialist Karen Bloch, MD, MPH; interpreter Eleazar Jimenez; orthopaedic surgeon Amir Abtahi, MD; infectious disease specialist Christina Fiske, MD, MPH; and otolaryngologist Sarah Rohde, MD, MMHC.
March 16, 2022

Teamwork returns man with severe post-COVID complications to his life

A multidisciplinary team at Vanderbilt helped José Ontiveros cope with a long list of severe complications arising from his COVID-19i infection.

March 14, 2022

Microbiome reflects COVID-19 severity

Characterization of the upper respiratory tract microbiome could help predict outcomes for COVID-19 infection, Vanderbilt researchers have discovered.